| +0.46 / +6.14%|
The 6 analysts offering 12-month price forecasts for Sunesis Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 15.00 and a low estimate of 6.00. The median estimate represents a +50.94% increase from the last price of 7.95.
The current consensus among 8 polled investment analysts is to Buy stock in Sunesis Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.